RNAC
Cartesian Therapeutics Inc.
$6.18
$0.00(0.00%)
37
Overall
40
Value
30
Tech
42
Quality
Market Cap
$166.48M
Volume
173.72K
52W Range
$5.60 - $15.57
Target Price
$35.57
Company Overview
| Mkt Cap | $166.48M | Price | $6.18 |
| Volume | 173.72K | Change | +0.00% |
| P/E Ratio | -2.2 | Open | $6.16 |
| Revenue | $38.3M | Prev Close | $6.18 |
| Net Income | $-77.4M | 52W Range | $5.60 - $15.57 |
| Div Yield | N/A | Target | $35.57 |
| Overall | 37 | Value | 40 |
| Quality | 42 | Technical | 30 |
No chart data available
Latest News
Cartesian Therapeutics Announces Board Member Murat Kalayoglu Resignation
TipRanks Auto-Generated Newsdesk•11 days ago
RNAC’s Descartes-08 Moves Toward Phase 2 in Rare Muscle Disease: What Investors Should Watch
TipRanks Clinical-Trials-Auto-Generated Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $6.18 | 0% | 173.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW